Nov 12, 2021/IndustryNewsGlobal/
The unexpected shifts in the global markets because of the sudden outbreak of the COVID-19 virus have brought many major and minor tremors to industries of all sizes including the Pediatric Vaccines Market.
It was estimated prior to this unanticipated outbreak that the
is likely to witness a promising
CAGR of 10.1%
during the forecast period. The prime factor contributing to the demand for pediatric vaccines is the advancements in healthcare sector and rising prevalence of chronic diseases.
Pediatric vaccines are biological preparations that are used to stimulate immunity against one or several diseases among children. These vaccines induce acquired immunity against ailments.
The report provides detailed insights into the market dynamics to enable informed business decision making and growth strategy formulation based on the opportunities present in the market.
Based on the product type,
the market is segmented as monovalent and multivalent. The monovalent segment held the larger share by product type in 2019 and is expected to maintain its dominance owing to safety and stability associated with such vaccines coupled with the ability to develop a prompt immune response.
Based on the technology type,
the market is segmented as live attenuated, inactivated, subunit, toxoid, conjugate, and others. The conjugate segment held the largest share by technology type in 2019 and is expected to maintain its vanguard owing to the growing awareness regarding pneumococcal and meningococcal infections.
Based on the application type,
the market is segmented as infectious diseases, cancer and allergy. The infectious disease segment held the largest share by application type in 2019 and is expected to maintain its lead on account of the rising awareness regarding infectious diseases across the globe coupled with the improving government initiatives to prevent such diseases.
In terms of regions,
North America is estimated to contribute for the largest market share over the forecast period. The largest share can be attributed to the huge R&D investments, presence of advanced healthcare infrastructure, presence of dominant market players, and high level of awareness regarding various medical conditions among general population. Asia-Pacific is expected to grow with the highest CAGR over the forecast period owing to the improving government initiatives to improve healthcare especially in emerging economies such as India and China.
Key players operating in the global Pediatric Vaccines market are-
Merck Sharp & Dohme Corp.
Mitsubishi Tanabe Pharma Corporation
This report offers high-quality insights and is the outcome of detailed research methodology comprising extensive secondary research, rigorous primary interviews with industry stakeholders and validation and triangulation with Stratview Research’s internal database and statistical tools.
analysis report discusses the following heads in great detail:
Market structure: Overview, industry life cycle analysis, supply chain analysis
COVID-19 Impact Assessment
Market environment analysis: Growth drivers and constraints, Porter’s five forces analysis, SWOT analysis
Market trend and forecast analysis
Market segment trend and forecast
Competitive landscape and dynamics: Market share, product portfolio, product launches, etc.
Attractive market segments and associated growth opportunities
Strategic growth opportunities for the existing and new players
Know more about Stratview Research:
Stratview Research is a global market research company and is known to offer custom research reports in varied fields such as aerospace & Defense, Advanced Materials, Aerospace & Defense, Automotive & Mass Transportation, Consumer Goods, Construction & Equipment, Electronics and Semiconductors, Energy & Utility, Healthcare & Life Sciences, and Oil & Gas. Our team makes sure to have deep research about the topics so that the most useful insights can be delivered to the professionals.
Need a detailed report? Get in touch with us: